ARTA
MRNS

A.R.T. Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

A.R.T. Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,430
Closed -$96K – 277
2020
Q2 		$96K Buy
+9,430
New +$86.7K 0.14% 193
2020
Q1 		– Sell
-18,221
Closed -$157K – 1082
2019
Q4 		$157K Sell
18,221
-2,322
-11% -$13K 0.01% 1183
2019
Q3 		$127K Buy
20,543
+13,517
+192% +$109K 0.01% 1246
2019
Q2 		$117K Sell
7,026
-5,837
-45% -$101K 0.01% 1174
2019
Q1 		$215K Buy
12,863
+6,863
+114% +$98.8K 0.01% 1061
2018
Q4 		$69K Buy
+6,000
New +$121K ﹤0.01% 1194
2018
Q2 		– Sell
-10,957
Closed -$167K – 1826
2018
Q1 		$167K Sell
10,957
-20,781
-65% -$495K 0.01% 1297
2017
Q4 		$1.03M Buy
+31,738
New +$855K 0.05% 606
2017
Q3 		– Sell
-12,165
Closed -$66K – 1739
2017
Q2 		$66K Buy
12,165
+3,240
+36% +$17.5K ﹤0.01% 1287
2017
Q1 		$63K Buy
8,925
+4,717
+112% +$25.4K ﹤0.01% 1314
2016
Q4 		$16K Sell
4,208
-5,567
-57% -$25.9K ﹤0.01% 1249
2016
Q3 		$71K Buy
+9,775
New +$66.1K 0.02% 580
2016
Q1 		– Sell
-6,242
Closed -$190K – 1706
2015
Q4 		$190K Buy
6,242
+1,161
+23% +$34.1K 0.01% 1238
2015
Q3 		$169K Buy
5,081
+932
+22% +$52.6K 0.01% 1191
2015
Q2 		$192K Buy
+4,149
New +$155K 0.01% 1294

Other funds holding MRNS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

A.R.T. Advisors's MRNS Position: Q3 2020 in Review

A.R.T. Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2020, closing a stake of 9,430 shares — an estimated $96K sold.

A.R.T. Advisors first reported a position in MRNS in Q2 2015 and held it in 15 quarters. The position peaked at $1.03M in Q4 2017. 77 funds tracked by Wall St. Rank hold MRNS as of Q3 2020.

  • A.R.T. Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 9,430 Marinus Pharmaceuticals, Inc shares in Q3 2020, an estimated $96K.
  • A.R.T. Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q2 2015 and held it in 15 quarters.
  • A.R.T. Advisors's Marinus Pharmaceuticals, Inc position peaked at $1.03M in Q4 2017.
  • 77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.